<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BW 1003C87, 5-(2,3,5-trichlorophenyl)-2,4-diaminopyrimidine <z:chebi fb="6" ids="6015">ethane</z:chebi> <z:chebi fb="1" ids="29214">sulphonic acid</z:chebi>, has been tested for its in vitro and in vivo effects on <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi> release in rat brain tissue, and for its cerebro-protective action in two <z:e sem="disease" ids="C1519106" disease_type="Experimental Model of Disease" abbrv="">rodent models</z:e> of <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>In rat brain slices the release of <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi> evoked by <z:chebi fb="0" ids="28051">veratrine</z:chebi> is inhibited by BW 1003C87 (IC50 = 1.6 microM) </plain></SENT>
<SENT sid="2" pm="."><plain>In anaesthetised rats with microdialysis probes implanted in the dorsal hippocampus the increase in extracellular <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi> evoked by <z:chebi fb="0" ids="28051">veratrine</z:chebi> is markedly reduced by co-infusion of BW 1003C87, 100 microM </plain></SENT>
<SENT sid="3" pm="."><plain>In anaesthetised rats with microdialysis probes implanted in the cortex and the caudate nucleus ipsilateral to a middle cerebral artery (<z:chebi fb="70" ids="34342">MCA</z:chebi>) occlusion the increase in dialysate <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi> concentration seen in the first 2 h following <z:chebi fb="70" ids="34342">MCA</z:chebi> occlusion is markedly attenuated by the prior administration of BW 1003C87, 20 mg/kg i.v </plain></SENT>
<SENT sid="4" pm="."><plain>In rats subjected to 10 min of bilateral common carotid <z:mp ids='MP_0006134'>artery occlusion</z:mp> the loss of CA1 pyramidal neurons (assessed 7 days later) is reduced by administration of BW 1003C87 (20 mg/kg i.v., at the time of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> and 4 h later) </plain></SENT>
<SENT sid="5" pm="."><plain>The volume of cortex showing infarction 72 h after unilateral <z:chebi fb="70" ids="34342">MCA</z:chebi> occlusion is reduced by treatment with BW 1003C87 (20 mg/kg, i.v., beginning 5 min after occlusion) </plain></SENT>
<SENT sid="6" pm="."><plain>Inhibition of <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi> release may provide a therapeutic approach in <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> as well as in <z:e sem="disease" ids="C0014544" disease_type="Disease or Syndrome" abbrv="">epilepsy</z:e> </plain></SENT>
</text></document>